AstraZeneca
Media playback is unsupported on your device
Video

AstraZeneca rejects new Pfizer bid

UK drugs company AstraZeneca has rejected an improved "final" takeover offer from US drugs giant Pfizer.

Pfizer had made a new offer of £55 per share, valuing AstraZeneca at about £69bn.

The BBC's Steph McGovern reports.

Go to next video: AstraZeneca rejects new Pfizer bid